What is BioPharma SHAKTI initiative?
Historical Background
Key Points
8 points- 1.
Focuses on deepening manufacturing capabilities in biopharmaceuticals.
- 2.
Aims to expand exports, especially to the Global South.
- 3.
Creates skilled employment in research, clinical trials, manufacturing, quality control, and regulatory functions.
- 4.
Links employment generation with export-led growth.
- 5.
Supports research and development in biopharmaceuticals.
- 6.
Encourages public-private partnerships.
- 7.
Provides incentives for manufacturing biopharmaceutical products in India.
- 8.
Strengthens regulatory framework for biopharmaceuticals.
Recent Developments
4 developmentsBudget 2026 proposes further investment in the initiative.
Emphasis on export promotion and job creation.
Collaboration with research institutions and industry.
Focus on developing affordable biopharmaceutical products.
This Concept in News
1 topicsFrequently Asked Questions
61. What is the BioPharma SHAKTI initiative and why is it important for UPSC GS Paper 3 (Economy)?
The BioPharma SHAKTI initiative aims to boost India's manufacturing capabilities in the biopharmaceutical sector. It is important for UPSC GS Paper 3 (Economy) because it directly relates to government policies on pharmaceutical manufacturing, export promotion, and employment generation, all of which are key aspects of the Indian economy.
2. What are the key provisions of the BioPharma SHAKTI initiative?
The BioPharma SHAKTI initiative focuses on several key areas to strengthen India's biopharmaceutical sector. These include:
- •Deepening manufacturing capabilities in biopharmaceuticals.
- •Expanding exports, especially to the Global South.
- •Creating skilled employment in research, clinical trials, manufacturing, quality control, and regulatory functions.
- •Linking employment generation with export-led growth.
- •Supporting research and development in biopharmaceuticals.
Exam Tip
Remember the focus areas: manufacturing, exports, employment, and R&D. This will help in answering questions related to the initiative's objectives and impact.
3. How does the BioPharma SHAKTI initiative aim to expand exports, especially to the Global South?
The initiative aims to expand exports by focusing on producing high-value biopharmaceuticals that are in demand in the Global South. By enhancing manufacturing capabilities and supporting research and development, India can offer competitive and affordable biopharmaceutical products to these markets.
4. What is the significance of the BioPharma SHAKTI initiative in the Indian economy?
The BioPharma SHAKTI initiative is significant because it aims to move India up the value chain in the pharmaceutical sector, from generic medicines to more complex biopharmaceuticals. This can lead to increased export revenue, job creation, and technological advancement, boosting the overall Indian economy.
5. What are the potential challenges in the implementation of the BioPharma SHAKTI initiative?
Some potential challenges include:
- •Securing sufficient funding for research and development.
- •Attracting and retaining skilled personnel in the biopharmaceutical sector.
- •Navigating complex regulatory pathways for biopharmaceutical products.
- •Ensuring quality control and compliance with international standards.
- •Competition from other countries with established biopharmaceutical industries.
6. How does India's BioPharma SHAKTI initiative compare with similar initiatives in other countries, particularly in terms of export promotion and job creation?
While the concept data doesn't provide specific details on other countries' initiatives, it's understood that many nations are also investing in their biopharmaceutical sectors. India's BioPharma SHAKTI initiative distinguishes itself by focusing on leveraging its existing strength in generic medicines to move into higher-value biopharmaceuticals, with a strong emphasis on exports to the Global South and linking employment generation to export-led growth.